Who owns the LENTINEXT trademark?

The LENTINEXT trademark is owned by BioDesign Lab Co., Ltd..

What class is the LENTINEXT trademark registered in?

The LENTINEXT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LENTINEXT?

The USPTO serial number for LENTINEXT is 79376166.

What is the registration number for LENTINEXT?

LENTINEXT is registered under USPTO registration number 7510377.

Sealvo

Home Search: LENTINEXTLENTINEXT #79376166

Back

Updated Oct 9, 2026·33 searches this week

View on USPTO TSDR Find similar marks

LEN

USPTO Trademark Record

REGISTERED

LENTINEXT

SN 79376166·Reg 7510377·Filed Jun 22, 2023

Owner BioDesign Lab Co., Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LENTINEXT (Serial No. 79376166), Registration No. 7510377, is a registered US trademark filed on Jun 22, 2023 by BioDesign Lab Co., Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: September 24, 2030

Mark Intelligence

LENTINEXT (Reg. #7510377) is a registered US trademark that has been protecting its owner, BioDesign Lab Co., Ltd., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

Jun 22, 2023

SERIAL

79376166

REG#

7510377

REGISTERED

Sep 24, 2024

Filing Information

StatusREGISTERED

Filing DateJun 22, 2023

Serial Number79376166

Registration No.7510377

Registration DateSep 24, 2024

Status DateSep 24, 2024

Published for OppositionJul 09, 2024

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

30 events

LIMITATION OF GOODS RECEIVED FROM IB

Jun 04, 2026

LIMITATION OF GOODS RECEIVED FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Mar 22, 2025

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Mar 02, 2025

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Mar 02, 2025

FINAL DISPOSITION NOTICE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Jan 25, 2025

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jan 08, 2025

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jan 08, 2025

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Dec 24, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Sep 24, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 24, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jul 09, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 09, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 19, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

May 30, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 30, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 30, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 30, 2024

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 30, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 09, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 09, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 09, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Apr 23, 2024

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Apr 03, 2024

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Apr 03, 2024

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 16, 2024

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Mar 15, 2024

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Mar 11, 2024

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Aug 15, 2023

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 11, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 10, 2023

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by BioDesign Lab Co., Ltd.

Additional USPTO filings from the same owner.

RET

RETRONEXT

79376165

BioDesign Lab Co., Ltd.

REGISTERED

Other Marks by Jong Park

Additional USPTO filings handled by the same attorney of record.

LEA

LEAD VAULT

79432627

REGISTERED

SIT

SIT SELF-INSIGHT THERAPY

79433311

REGISTERED

MUI

MUILLI

88204358

REGISTERED

FVR

FVRTS

99219145

REGISTERED

LENTINEXT

Run a conflict check

Other Marks by BioDesign Lab Co., Ltd.

Other Marks by Jong Park

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company